These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 13430892

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Personal experience and preliminary results in serpasil treatment of schizophrenia].
    BOGICEVIC Dj, VELICKOVIC R, STANOJEV M.
    Srp Arh Celok Lek; 1957 Mar; 85(3):283-92. PubMed ID: 13455224
    [No Abstract] [Full Text] [Related]

  • 23. [Reserpine management of chronic schizophrenia and acute anxiety].
    LJUNGBERG E.
    Sven Lakartidn; 1956 Aug 24; 53(34):2128-40. PubMed ID: 13360699
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A note on a controlled experiment using reserpine, an extract of Alstonia constricta and placebo.
    COCKBURN AS, MILLER GD.
    Med J Aust; 1959 May 16; 46(1 20):662-4. PubMed ID: 13656047
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical comparison of tetrabenazine (Ro 1-9569), reserpine and placebo in chronic schizophrenics.
    SMITH ME.
    Dis Nerv Syst; 1960 Mar 16; 21(3)Suppl():120-3. PubMed ID: 13832091
    [No Abstract] [Full Text] [Related]

  • 31. Drug and milieu effects with chronic schizophrenics.
    RASHKIS HA, SMARR ER.
    AMA Arch Neurol Psychiatry; 1957 Jul 16; 78(1):89-94. PubMed ID: 13434530
    [No Abstract] [Full Text] [Related]

  • 32. Investigations into the so-called reserpine Parkinsonoid in chronic schizophrenics and its treatment with orphenadrine (disipal).
    van ANDEL.
    Folia Psychiatr Neurol Neurochir Neerl; 1959 Oct 16; 62():476-88. PubMed ID: 13793294
    [No Abstract] [Full Text] [Related]

  • 33. [Hyperkinetic crises of hemiballistic type in a schizophrenic treated with reserpine].
    BARUCCI M, MORI F.
    Riv Patol Nerv Ment; 1957 Oct 16; 78(3):1013-6. PubMed ID: 13528782
    [No Abstract] [Full Text] [Related]

  • 34. [Further contributions to study of the therapeutic effects of combined reserpine and orphenadrine in massive doses in chronic schizophrenia].
    BALLERINI A, GERMANO G.
    Rass Studi Psichiatr; 1961 Oct 16; 50():215-20. PubMed ID: 13686389
    [No Abstract] [Full Text] [Related]

  • 35. [Reconsideration of reserpine in the treatment of schizophrenia].
    Kubo S, Kodama H, Kimura N.
    Iryo; 1968 May 16; 22(5):578-82. PubMed ID: 5699914
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of reserpine in acute catatonic schizophrenia.
    HITE KE, BRAUN M.
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1960 May 16; 21():217-9. PubMed ID: 13714671
    [No Abstract] [Full Text] [Related]

  • 38. [On the treatment of asymptomatic schizophrenia with very high doses of reserpine and orphenadrine].
    AVENARIUS R, FISCHER H, MEYER JE.
    Psychiatr Neurol (Basel); 1961 May 16; 142():13-30. PubMed ID: 13685260
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.